Global Women Health Therapeutics Market Research Report 2023

Report ID: 1991695 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Women Health Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Menopause
        1.2.3 Endometriosis
        1.2.4 Postmenopausal osteoporosis
        1.2.5 Breast cancer
        1.2.6 Polycystic ovary syndrome
        1.2.7 Infertility
        1.2.8 Gynecological cancer
    1.3 Market by Application
        1.3.1 Global Women Health Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Diagnostic and imaging centers
        1.3.3 Hospitals and clinics
        1.3.4 Home care
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Women Health Therapeutics Market Perspective (2017-2028)
    2.2 Women Health Therapeutics Growth Trends by Region
        2.2.1 Women Health Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Women Health Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Women Health Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Women Health Therapeutics Market Dynamics
        2.3.1 Women Health Therapeutics Industry Trends
        2.3.2 Women Health Therapeutics Market Drivers
        2.3.3 Women Health Therapeutics Market Challenges
        2.3.4 Women Health Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Women Health Therapeutics Players by Revenue
        3.1.1 Global Top Women Health Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Women Health Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Women Health Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Women Health Therapeutics Revenue
    3.4 Global Women Health Therapeutics Market Concentration Ratio
        3.4.1 Global Women Health Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Women Health Therapeutics Revenue in 2021
    3.5 Women Health Therapeutics Key Players Head office and Area Served
    3.6 Key Players Women Health Therapeutics Product Solution and Service
    3.7 Date of Enter into Women Health Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Women Health Therapeutics Breakdown Data by Type
    4.1 Global Women Health Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Women Health Therapeutics Forecasted Market Size by Type (2023-2028)
5 Women Health Therapeutics Breakdown Data by Application
    5.1 Global Women Health Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Women Health Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Women Health Therapeutics Market Size (2017-2028)
    6.2 North America Women Health Therapeutics Market Size by Country (2017-2022)
    6.3 North America Women Health Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Women Health Therapeutics Market Size (2017-2028)
    7.2 Europe Women Health Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Women Health Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Women Health Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Women Health Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Women Health Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Women Health Therapeutics Market Size (2017-2028)
    9.2 Latin America Women Health Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Women Health Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Women Health Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Women Health Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Women Health Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Women Health Therapeutics Introduction
        11.1.4 Novartis Revenue in Women Health Therapeutics Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 Abbott
        11.2.1 Abbott Company Detail
        11.2.2 Abbott Business Overview
        11.2.3 Abbott Women Health Therapeutics Introduction
        11.2.4 Abbott Revenue in Women Health Therapeutics Business (2017-2022)
        11.2.5 Abbott Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Women Health Therapeutics Introduction
        11.3.4 Pfizer Revenue in Women Health Therapeutics Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Eli Lilly
        11.4.1 Eli Lilly Company Detail
        11.4.2 Eli Lilly Business Overview
        11.4.3 Eli Lilly Women Health Therapeutics Introduction
        11.4.4 Eli Lilly Revenue in Women Health Therapeutics Business (2017-2022)
        11.4.5 Eli Lilly Recent Development
    11.5 Bayer
        11.5.1 Bayer Company Detail
        11.5.2 Bayer Business Overview
        11.5.3 Bayer Women Health Therapeutics Introduction
        11.5.4 Bayer Revenue in Women Health Therapeutics Business (2017-2022)
        11.5.5 Bayer Recent Development
    11.6 Merck
        11.6.1 Merck Company Detail
        11.6.2 Merck Business Overview
        11.6.3 Merck Women Health Therapeutics Introduction
        11.6.4 Merck Revenue in Women Health Therapeutics Business (2017-2022)
        11.6.5 Merck Recent Development
    11.7 Roche
        11.7.1 Roche Company Detail
        11.7.2 Roche Business Overview
        11.7.3 Roche Women Health Therapeutics Introduction
        11.7.4 Roche Revenue in Women Health Therapeutics Business (2017-2022)
        11.7.5 Roche Recent Development
    11.8 Novo Nordisk
        11.8.1 Novo Nordisk Company Detail
        11.8.2 Novo Nordisk Business Overview
        11.8.3 Novo Nordisk Women Health Therapeutics Introduction
        11.8.4 Novo Nordisk Revenue in Women Health Therapeutics Business (2017-2022)
        11.8.5 Novo Nordisk Recent Development
    11.9 Oasmia
        11.9.1 Oasmia Company Detail
        11.9.2 Oasmia Business Overview
        11.9.3 Oasmia Women Health Therapeutics Introduction
        11.9.4 Oasmia Revenue in Women Health Therapeutics Business (2017-2022)
        11.9.5 Oasmia Recent Development
    11.10 Sanofi
        11.10.1 Sanofi Company Detail
        11.10.2 Sanofi Business Overview
        11.10.3 Sanofi Women Health Therapeutics Introduction
        11.10.4 Sanofi Revenue in Women Health Therapeutics Business (2017-2022)
        11.10.5 Sanofi Recent Development
    11.11 Takeda
        11.11.1 Takeda Company Detail
        11.11.2 Takeda Business Overview
        11.11.3 Takeda Women Health Therapeutics Introduction
        11.11.4 Takeda Revenue in Women Health Therapeutics Business (2017-2022)
        11.11.5 Takeda Recent Development
    11.12 Allergan
        11.12.1 Allergan Company Detail
        11.12.2 Allergan Business Overview
        11.12.3 Allergan Women Health Therapeutics Introduction
        11.12.4 Allergan Revenue in Women Health Therapeutics Business (2017-2022)
        11.12.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Women Health Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Menopause
    Table 3. Key Players of Endometriosis
    Table 4. Key Players of Postmenopausal osteoporosis
    Table 5. Key Players of Breast cancer
    Table 6. Key Players of Polycystic ovary syndrome
    Table 7. Key Players of Infertility
    Table 8. Key Players of Gynecological cancer
    Table 9. Global Women Health Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Women Health Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Women Health Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Women Health Therapeutics Market Share by Region (2017-2022)
    Table 13. Global Women Health Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Women Health Therapeutics Market Share by Region (2023-2028)
    Table 15. Women Health Therapeutics Market Trends
    Table 16. Women Health Therapeutics Market Drivers
    Table 17. Women Health Therapeutics Market Challenges
    Table 18. Women Health Therapeutics Market Restraints
    Table 19. Global Women Health Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Women Health Therapeutics Market Share by Players (2017-2022)
    Table 21. Global Top Women Health Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women Health Therapeutics as of 2021)
    Table 22. Ranking of Global Top Women Health Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Women Health Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Women Health Therapeutics Product Solution and Service
    Table 26. Date of Enter into Women Health Therapeutics Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Women Health Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Women Health Therapeutics Revenue Market Share by Type (2017-2022)
    Table 30. Global Women Health Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Women Health Therapeutics Revenue Market Share by Type (2023-2028)
    Table 32. Global Women Health Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Women Health Therapeutics Revenue Market Share by Application (2017-2022)
    Table 34. Global Women Health Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Women Health Therapeutics Revenue Market Share by Application (2023-2028)
    Table 36. North America Women Health Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Women Health Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Women Health Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe Women Health Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific Women Health Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific Women Health Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America Women Health Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America Women Health Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa Women Health Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa Women Health Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Novartis Company Detail
    Table 47. Novartis Business Overview
    Table 48. Novartis Women Health Therapeutics Product
    Table 49. Novartis Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Novartis Recent Development
    Table 51. Abbott Company Detail
    Table 52. Abbott Business Overview
    Table 53. Abbott Women Health Therapeutics Product
    Table 54. Abbott Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Abbott Recent Development
    Table 56. Pfizer Company Detail
    Table 57. Pfizer Business Overview
    Table 58. Pfizer Women Health Therapeutics Product
    Table 59. Pfizer Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Pfizer Recent Development
    Table 61. Eli Lilly Company Detail
    Table 62. Eli Lilly Business Overview
    Table 63. Eli Lilly Women Health Therapeutics Product
    Table 64. Eli Lilly Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Eli Lilly Recent Development
    Table 66. Bayer Company Detail
    Table 67. Bayer Business Overview
    Table 68. Bayer Women Health Therapeutics Product
    Table 69. Bayer Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Bayer Recent Development
    Table 71. Merck Company Detail
    Table 72. Merck Business Overview
    Table 73. Merck Women Health Therapeutics Product
    Table 74. Merck Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Merck Recent Development
    Table 76. Roche Company Detail
    Table 77. Roche Business Overview
    Table 78. Roche Women Health Therapeutics Product
    Table 79. Roche Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Roche Recent Development
    Table 81. Novo Nordisk Company Detail
    Table 82. Novo Nordisk Business Overview
    Table 83. Novo Nordisk Women Health Therapeutics Product
    Table 84. Novo Nordisk Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. Novo Nordisk Recent Development
    Table 86. Oasmia Company Detail
    Table 87. Oasmia Business Overview
    Table 88. Oasmia Women Health Therapeutics Product
    Table 89. Oasmia Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Oasmia Recent Development
    Table 91. Sanofi Company Detail
    Table 92. Sanofi Business Overview
    Table 93. Sanofi Women Health Therapeutics Product
    Table 94. Sanofi Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 95. Sanofi Recent Development
    Table 96. Takeda Company Detail
    Table 97. Takeda Business Overview
    Table 98. Takeda Women Health TherapeuticsProduct
    Table 99. Takeda Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. Takeda Recent Development
    Table 101. Allergan Company Detail
    Table 102. Allergan Business Overview
    Table 103. Allergan Women Health TherapeuticsProduct
    Table 104. Allergan Revenue in Women Health Therapeutics Business (2017-2022) & (US$ Million)
    Table 105. Allergan Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Women Health Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Menopause Features
    Figure 3. Endometriosis Features
    Figure 4. Postmenopausal osteoporosis Features
    Figure 5. Breast cancer Features
    Figure 6. Polycystic ovary syndrome Features
    Figure 7. Infertility Features
    Figure 8. Gynecological cancer Features
    Figure 9. Global Women Health Therapeutics Market Share by Application in 2021 & 2028
    Figure 10. Diagnostic and imaging centers Case Studies
    Figure 11. Hospitals and clinics Case Studies
    Figure 12. Home care Case Studies
    Figure 13. Women Health Therapeutics Report Years Considered
    Figure 14. Global Women Health Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Women Health Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Women Health Therapeutics Market Share by Region: 2021 VS 2028
    Figure 17. Global Women Health Therapeutics Market Share by Players in 2021
    Figure 18. Global Top Women Health Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women Health Therapeutics as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Women Health Therapeutics Revenue in 2021
    Figure 20. North America Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Women Health Therapeutics Market Share by Country (2017-2028)
    Figure 22. United States Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Women Health Therapeutics Market Share by Country (2017-2028)
    Figure 26. Germany Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Women Health Therapeutics Market Share by Region (2017-2028)
    Figure 34. China Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Women Health Therapeutics Market Share by Country (2017-2028)
    Figure 42. Mexico Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Women Health Therapeutics Market Share by Country (2017-2028)
    Figure 46. Turkey Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Women Health Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Novartis Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 49. Abbott Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 50. Pfizer Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 51. Eli Lilly Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 52. Bayer Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 53. Merck Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 54. Roche Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 55. Novo Nordisk Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 56. Oasmia Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 57. Sanofi Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 58. Takeda Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 59. Allergan Revenue Growth Rate in Women Health Therapeutics Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Abbott
Pfizer
Eli Lilly
Bayer
Merck
Roche
Novo Nordisk
Oasmia
Sanofi
Takeda
Allergan
Frequently Asked Questions
Women Health Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Women Health Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Women Health Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports